Optimal therapy scheduling based on a pair of collaterally sensitive drugs
From MaRDI portal
Publication:1670458
DOI10.1101/196824 10.1007/s11538-018-0434-2; 10.1101/196824zbMath1396.92040OpenAlexW2764019985MaRDI QIDQ1670458
Nara Yoon, Robert Vander Velde, Andriy Marusyk, Jacob G. Scott
Publication date: 5 September 2018
Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1101/196824
Applications of optimal control and differential games (49N90) Medical applications (general) (92C50)
Related Items
Modelling bistable tumour population dynamics to design effective treatment strategies, Scheduling collateral sensitivity‐based cycling therapies toward eradication of drug‐resistant infections, Inferring density-dependent population dynamics mechanisms through rate disambiguation for logistic birth-death processes, Theoretical modeling of collaterally sensitive drug cycles: shaping heterogeneity to allow adaptive therapy, The impact of competition between cancer cells and healthy cells on optimal drug delivery
Cites Work
- The mathematical modelling of adjuvant chemotherapy scheduling: incorporating the effects of protocol rest phases and pharmacokinetics
- The worst drug rule revisited: mathematical modeling of cyclic cancer treatments
- A single-cell approach in modeling the dynamics of tumor microregions
- A model for the resistance of tumor cells to cancer chemotherapeutic agents
- A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy
- The application of mathematical modelling to aspects of adjuvant chemotherapy scheduling
- An elementary approach to modeling drug resistance in cancer
- Optimal policies of non-cross-resistant chemotherapy on Goldie and Coldman's cancer model
- The influence of toxicity constraints in models of chemotherapeutic protocol escalation